Design
CFS
GROUP B
The single-center, randomized, controlled trial was conducted at the Center of Preventive Medicine, Hospital of Chengdu University of TCM. This trial strictly adhered to the rules of the Declaration of Helsinki and the Good Clinical Practice Guidelines, and it was registered with a unique registration number (ChiCTR2000041000) at The CFS patients were randomly allocated to either the 60-min Long-snake-like moxibustion group (Group A) or the 30-min Long-snake-like moxibustion group (Group B) in a 1:1 ratio, with a treatment period of 4 weeks consisting of 3 times per week, every other day.